Talditercept alfa

Talditercept alfa Uses, Dosage, Side Effects, Food Interaction and all others data.

Talditercept alfa is under investigation in clinical trial NCT03039686 (Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy).

Trade Name Talditercept alfa
Generic Talditercept alfa
Talditercept alfa Other Names Adnectin, anti-(human growth differentiation factor 8) (synthetic clone prd-1474 fibronectin type iii tenth domain (10fn3)-based isoform, Bms-986089 (fully human anti-myostatin adnectin), Immunoglobulin g1 (human fc fragment) fusion protein with peptide (synthetic 17-amino acid linker) fusion protein with adnectin, anti-(human growth differentiation factor 8) (human clone bms-986089 fibronectin tenth type iii domain-derived), dimer, Taldefgrobep alfa, Talditercept alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Talditercept alfa
Talditercept alfa

Innovators Monograph

You find simplified version here Talditercept alfa


*** Taking medicines without doctor's advice can cause long-term problems.
Share